Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) posted its quarterly earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.04), Yahoo Finance reports. Pharma-Bio Serv had a negative net margin of 0.05% and a negative return on equity of 0.04%. The company had revenue of $2.42 million during the quarter, compared to the consensus estimate of $3.50 million.

Pharma-Bio Serv Price Performance

Shares of Pharma-Bio Serv stock opened at $0.63 on Tuesday. The business has a fifty day simple moving average of $0.62 and a 200-day simple moving average of $0.69. Pharma-Bio Serv has a 12 month low of $0.52 and a 12 month high of $1.09.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.